Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment.
Item Type:Journal Article
Citation:Michielsen AJ, Ryan EJ, O'Sullivan JN, Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment., Oncoimmunology, 1, 8, 2012, 1445-1447
onci-1-1445.pdf (PDF) 177.1Kb
we demonstrated that dendritic cell (DC) inhibition by tumor-conditioned media in the presence or absence of bevacizumab correlates with colorectal cancer patient survival. Monitoring the influence of the tumor microenvironment on infiltrating immune cells may offer an avenue for the discovery of biomarkers to guide the use of bevacizumab
Author: O'SULLIVAN, JACINTHA
Type of material:Journal Article
Availability:Full text available